NRGGU013
OPEN TO ACCRUAL
Phase III SBRT vs Conventional or Moderate Hypofractionation for High-Risk Prostate Cancer
NWU22-12-01
OPEN TO ACCRUAL
PH2 Placebo-Controlled Trial of Urolithin a in Prostate Cancer Undergoing Radical Prostatectomy
S2312
OPEN TO ACCRUAL
Phase 3 Study of Cabazitaxel with or without Carboplatin in MCRPC Patients
UW22067
OPEN TO ACCRUAL
PET CT Characterization of Treatment Resistance of AR-targeted therapies in mCRPC
UW24097
OPEN TO ACCRUAL
Phase 2 Lesion-Directed Radiation in Prostate Cancer Previously Treated w Testosterone Suppression
UW24109
OPEN TO ACCRUAL
Ph1 Safety+Tolerability of Novel ACK1 Inhibitor R-9bMS in Patients with Prostate Cancer - PHAROS
UW25025
OPEN TO ACCRUAL
Pilot trial of pTVG-HP+Nivo+targeted ablation of resistant lesions in Non-Castrate Recurrent OMPC
UW26012
OPEN TO ACCRUAL
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
UW26015
OPEN TO ACCRUAL
Exact Sciences urine collection study